VIGATO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 13
Totale 13
Nazione #
IT - Italia 12
FR - Francia 1
Totale 13
Città #
Turin 7
Alessandria 2
Rivoli 2
Borgaro Torinese 1
Totale 12
Nome #
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer, file 95bb6e43-8fbf-4e81-8b56-6ed88d7a749f 5
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER, file deffeefd-18ce-465e-8214-ab55208f9682 2
Design of new human Dihydroorotate Dehydrogenase inhibitors: amide bioisosterism in MEDS433 optimization, file e27ce434-bed2-2581-e053-d805fe0acbaa 2
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2-hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic, file 0f183a53-b692-48a9-996c-fc7c1c008917 1
Improvement of Metabolic Weakness of New Dihydroorotate Dehydrogenase Inhibitors Based on 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold to Target Myeloid Leukemias, file 83388e83-ad81-4a04-93f3-2b0624b87ea4 1
Important Steps into Drug Development of MEDS433, a Potent Human Dihydroorotate Dehydrogenase Inhibitor based on the 2-hydroxypyrazolo[1,5-a] Pyridine Scaffold, file ba92237a-a9d9-4a82-8262-6f5eaf4c9219 1
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer, file e27ce434-eab9-2581-e053-d805fe0acbaa 1
Totale 13
Categoria #
all - tutte 18
article - articoli 0
book - libri 0
conference - conferenze 8
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20237 0 0 0 0 2 2 0 0 0 0 2 1
2023/20246 0 0 0 0 0 0 1 4 1 0 0 0
Totale 13